Scholarlink

<p>This study aimed to investigate potential improvements when implementing endometrial receptivity analysis (ERA)-guided personalized embryo transfer (pET) using euploid blastocyst in patients with one or more previous failed embryo transfers. A total of 270 patients with one or more previous failed embryo transfers were enrolled between 2017 and 2021 in this multicenter retrospective study. These patients were divided into two groups: study cases (ERA-guided pET) (<i>n</i> = 200) or controls (standard embryo transfer) (<i>n</i> = 70). Clinical outcomes compared were pregnancy rate (PR), implantation rate (IR), ongoing pregnancy rate (OPR), and live birth rate (LBR). Clinical results in terms of PR, OPR, and LBR were significantly higher when performing ERA-guided pET (PR: 65.0%; OPR: 49.0%; LBR: 48.2%) compared to standard embryo transfer (PR: 37.1%; OPR: 27.1%; LBR: 26.1%) (<i>P</i> &lt; 0.01). Logistic regression was applied to examine the correlation between ERA and the primary outcome measured, OPR, including demographic variables as covariates. The effect of ERA was significantly associated with OPR (<i>P</i> = 0.002; aOR 2.8, 95% CI 1.5–5.5); furthermore, OPR decreased significantly when body mass index (BMI) values increased (<i>P</i> = 0.04; aOR 0.9, 95% CI 0.8–0.98). These findings support the potential of ERA-guided pET to improve clinical outcomes and address the challenges encountered by patients with previous implantation failures.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical outcomes following endometrial receptivity assessment-guided personalized euploid embryo transfer in patients with previous implantation failures

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月15日

查看全文
  • María Ruiz-Alonso,
  • Carlos Gómez,
  • Tiffany Stankewicz,
  • José A. Castellón,
  • Antonio Díez-Juan,
  • Eva Gómez,
  • Carmen Rubio,
  • Carlos Simón,
  • Diana Valbuena

摘要

This study aimed to investigate potential improvements when implementing endometrial receptivity analysis (ERA)-guided personalized embryo transfer (pET) using euploid blastocyst in patients with one or more previous failed embryo transfers. A total of 270 patients with one or more previous failed embryo transfers were enrolled between 2017 and 2021 in this multicenter retrospective study. These patients were divided into two groups: study cases (ERA-guided pET) (n = 200) or controls (standard embryo transfer) (n = 70). Clinical outcomes compared were pregnancy rate (PR), implantation rate (IR), ongoing pregnancy rate (OPR), and live birth rate (LBR). Clinical results in terms of PR, OPR, and LBR were significantly higher when performing ERA-guided pET (PR: 65.0%; OPR: 49.0%; LBR: 48.2%) compared to standard embryo transfer (PR: 37.1%; OPR: 27.1%; LBR: 26.1%) (P < 0.01). Logistic regression was applied to examine the correlation between ERA and the primary outcome measured, OPR, including demographic variables as covariates. The effect of ERA was significantly associated with OPR (P = 0.002; aOR 2.8, 95% CI 1.5–5.5); furthermore, OPR decreased significantly when body mass index (BMI) values increased (P = 0.04; aOR 0.9, 95% CI 0.8–0.98). These findings support the potential of ERA-guided pET to improve clinical outcomes and address the challenges encountered by patients with previous implantation failures.